Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics

Summary

The purpose of this study is to determine whether Q cells separated from the glioma sample are determinants in treatment response and prognosis of glioma patients

Conditions

• Glioblastoma
• Malignant Glioma

Sponsors & Collaborators

• Guangzhou General Hospital of Guangzhou Military Command

  collaborator OTHER

• Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

  collaborator OTHER

• First Affiliated Hospital of Fujian Medical University

  collaborator OTHER

• The First Affiliated Hospital of Nanchang University

  collaborator OTHER

• Capital Medical University

  collaborator OTHER

• Tianjin Medical University General Hospital

  collaborator OTHER

• Shenzhen Second People's Hospital

  collaborator OTHER

• Huashan Hospital

  collaborator OTHER

• West China Hospital

  collaborator OTHER

• Xiangya Hospital of Central South University

  collaborator OTHER

• The First Hospital of Jilin University

  collaborator OTHER

• First Hospital of China Medical University

  collaborator OTHER

• Qilu Hospital of Shandong University

  collaborator OTHER

• Second Affiliated Hospital of Soochow University

  collaborator OTHER

• Sun Yat-sen University

  collaborator OTHER

• Guangzhou First People's Hospital

  collaborator OTHER

• Xi'an Jiaotong University

  collaborator OTHER

• Southern Medical University, China

  collaborator OTHER

• Second Affiliated Hospital of Guangzhou Medical University

  collaborator OTHER

• Nanfang Hospital, Southern Medical University

  lead OTHER

Principal Investigators

• Songtao Qi, Doctor · Nanfang Glioma centre, Guangzhou, China

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2014-03-31

Primary Completion

2016-12-31

Completion

2017-03-31

Countries

• China

Study Locations